Search
for
Sort by
Research 31–60 of 1000+
- 170 Forecasting Phase 3 Dose-Response for Abrocitinib, an Oral Janus Kinase 1 Selective Inhibitor, Using Investigator’s Global Assessment and Eczema Area and Severity Index
- Genomic and phenotypic characterization of Investigator Global Assessment (IGA) scale-based endotypes in atopic dermatitis
- Referee report. For: Comparison between Tazarotene 0.05% gel and Adapelene 0.1% gel in acne patients [version 1; peer review: 1 approved with reservations]
- Evaluating the combined efficacy of oral isotretinoin and topical tacrolimus versus oral finasteride and topical tacrolimus in frontal fibrosing alopecia—A randomized controlled trial
- British Hair and Nail Society
- Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study
- Assessing the Efficacy and Quality of Life Improvements of Botulinum Toxin Type A With Topical Minoxidil versus Topical Minoxidil in Male Androgenetic Alopecia: A Randomized Controlled Trial
- Evaluation of the safety and effectiveness of intradermal administration of QR678 Neo<sup>®</sup> hair growth factor formulation: A phase‐IV, open‐label, single‐arm multi‐ethnicity clinical trial
- Efficacy of autologous dermal sheath cup cell transplantation in male and female pattern hair loss: A Single‐Arm, Multi‐Center, phase III equivalent clinical study
- 604 Comparison of 1064-nm Nd:YAG picosecond lasers using fractional micro-lens array vs. ablative fractional 2940-nm Er:YAG lasers for the treatment of atrophic acne scar in Asians: A 20-week prospective, randomized, split-face, controlled trial
- BH04 Review of a dermatology nurse-led hair service
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Comparative Clinical Study Evaluating the Efficacy and Safety of Topical 5% Cetosomal Minoxidil and Topical 5% Alcohol-Based Minoxidil Solutions for the Treatment of Androgenetic Alopecia in Indian Men
- Topical finasteride 0.25% in HPCH spray for androgenetic alopecia: a single-center retrospective study
- Effectiveness and safety of the ablative fractional 2940-nm Er: YAG laser for the treatment of androgenetic alopecia
- Facial Psoriasis Log-based Area and Severity Index: A valid and reliable severity measurement method detecting improvement of facial psoriasis in clinical practice settings
- Adherence to topical hydrocortisone 17-butyrate 0.1% in different vehicles in adults with atopic dermatitis
- Effectiveness and Safety of Topical Finasteride for Male Androgenetic Alopecia: Real World Data
- Long-term (10-year) efficacy of finasteride in 523 Japanese men with androgenetic alopecia
- Efficacy and safety of spironolactone versus bicalutamide in female pattern hair loss: A retrospective comparative study
- P153 : Safety and Efficacy of botulinum toxin on male pattern baldness
- P196 : Home-use microneedle in the treatment of pattern hair loss: efficacy and safety Department of Dermatology
- 5 mg/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss
- Effect of intralesional injection of autologous platelet rich plasma in patterned hair loss
- Effects of Finasteride (1 mg) on Hair Transplant
- Effects of Finasteride (1 mg) on Hair Transplant
- Microneedling plus topical dutasteride solution for androgenetic alopecia: a randomized placebo‐controlled study
- Platelet-Rich Plasma Treatment for Endocrine-Induced Alopecia and Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors: A Randomized, Controlled, Pilot Study
- Efficacy and tolerability of an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with hair loss (androgenetic alopecia, AGA or FAGA or telogen effluvium). A prospective, randomized, 3‐month, controlled, assessor‐blinded study
- Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)*